Skip to main content
. 2011 Oct 24;122(Pt 4):183–192. doi: 10.1042/CS20110200

Table 3. Autonomic and neurohormonal profile in CFS–POTS and non-CFS–POTS.

Values are means±S.E.M. DBP, diastolic BP; SBP, systolic BP; LF, low frequency; HF, high frequency; RRI, R–R heart rate interval. Control values from the Autonomic Dysfunction Center Database at Vanderbilt University are presented as a reference.

Non-CFS POTS CFS-POTS Controls
Test Value n Value n P value Value n
Orthostatic stress test
 Supine
  SBP (mmHg) 104±3 17 108±2 30 0.385 100±2 22
  DBP (mmHg) 67±2 17 67±2 30 0.963 65±2 22
  HR (beats/min) 75±3 17 73±1 30 0.495 62±2 22
 10 min standing
  SBP (mmHg) 109±4 15 113±4 28 0.509 100±3 22
  DBP (mmHg) 72±2 15 73±2 28 0.755 69±2 22
  HR (beats/min) 115±6 15 122±3 28 0.244 85±2 22
 Total standing time (min) 21±2 17 20±2 30 0.902 27±2 22
 ΔHR at maximal tolerance (beats/min)* 40±4 17 51±3 30 0.030 26±3 22
Valsalva manoeuvre
 Early phase II ΔSBP (mmHg) −24±4 17 −24±3 27 0.838 −14±3 21
 Late phase II ΔSBP (mmHg) 11±2 17 18±3 27 0.041 10±2 21
 Phase II ΔHR (beats/min) 37±4 17 42±3 27 0.642 25±3 21
 Phase IV overshoot ΔSBP (mmHg) 31±5 17 36±3 30 0.298 12±3 21
 Valsalva manoeuvre ratio 1.95±0.41 17 2.01±0.06 30 0.580 1.62±0.07 21
Cold pressor ΔSBP (mmHg) 20±2 17 20±2 29 1.000 20±3 20
LFRRI (ms2) 371±92 17 564±97 30 0.293 921±161 22
HFRRI (ms2) 322±109 17 338±58 30 0.598 1372±321 22
LFRRI/HFRRI 2.0±0.3 17 2.3±0.2 30 0.406 1.1±0.2 22
LFSBP (mmHg2) 4.8±1.0 17 6.3±0.7 30 0.019 3.5±0.6 22
Plasma noradrenaline (pg/ml)
 Supine 173±27 17 203±27 30 0.232 189±15 22
 Upright 779±131 17 635±51 30 0.587 388±18 22

*HR changes (ΔHR) from supine to standing at the time of maximal orthostatic tolerance.

†BP and HR responses are given as the change (Δ) compared with baseline.

‡BP recovery from early to late phase II of the Valsalva manoeuvre.